Use of Alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
Details for Australian Patent Application No. 2005203400 (hide)
International Classifications
Event Publications
18 August 2005 Complete Application Filed
Priority application(s): 200402282 24.09.04 ES
12 January 2006 Change of Name(s) of Applicant(s), Section 104
Probitas Pharma, S.A. The name of the applicant has been changed to Grifols, S.A.
13 April 2006 Application Open to Public Inspection
Published as AU-B-2005203400
18 January 2007 Application Accepted
Published as AU-B-2005203400
2 August 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005203401-Targeting bioactive materials via somatostatin receptors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser